 |
| Inga-Marie Schaefer, MD |
Inga-Marie Schaefer, MD, of the Department of Pathology, won the Liddy Shriver Early Career Research Award from the Connective Tissue Oncology Society (CTOS) for her research on sarcomas, a category of tumors that originates in the bones and soft tissues. She also received the Sperling Family Fellowship in Precision Healthcare from the Brigham and the Broad Institute of MIT and Harvard, which will fund her current research project on sarcomas, "Exploiting Cell Cycle Perturbations in Gastrointestinal Stromal Tumors for Therapeutic Targeting.”
The Liddy Shriver Early Career Research Award is named in memory of Liddy Shriver, who died at age 37 from Ewing’s sarcoma in 2004. This program supports and celebrates the achievements of younger researchers within the global sarcoma community.
The Sperling Family Fellowship supports innovative projects with the goal of leveraging the strengths of two world-renowned institutions — the superb clinical care, expert bioinformatics and rich data sources of the Brigham, and the basic science, computational and genomics sophistication of the Broad Institute — to advance a translational research project with the potential to transform how we care for patients.
With these awards, Schaefer will continue her research on sarcomas with her project on gastrointestinal stromal tumors (GISTs), which are a type of tumor that forms in the tissues of the gastrointestinal tract. Her study investigates the mechanisms of cell cycle perturbations in GISTs — aiming to pave the way for the discovery of novel diagnostic and therapeutic strategies for their treatment.
Schaefer leads the Schaefer Lab, where her research team uses a combination of genomic, structural and multiplexed imaging studies to investigate the biology, genetics and molecular mechanisms of sarcomas, with the goal of developing novel therapeutics.
CTOS is an international group of physicians and scientists aiming to advance the care of patients with connective tissue tumors and to improve understanding of the biology of these tumors through basic and clinical research.
